The clinical trial supplies market is projected to reach USD 6.3 Billion by 2028 from USD 3.9 Billion in 2023, at a CAGR of 9.9% during the forecast period. Growth in the clinical trial supplies market can be attributed to factors such as the collaborations and partnerships among market players for providing the clinical trial supplies services and increasing R&D expenditure in pharmaceutical and biotechnology companies. Rise in number of clinical trials and strong government support for streamlining clinical trials are some of the major elements uplifting the market growth.
The clinical trial supplies market is highly competitive. The prominent players operating in this market include Thermo Fisher Scientific Inc. (US), Catalent, Inc. (US), Eurofins Scientific (France), Piramal Pharma Solutions (India), PRA Health Sciences (US), Parexel International (MA) Corporation. (US), Marken (US), Biocair (UK), Almac Group (UK), Sharp Services, LLC (US), PCI Pharma Services (US), Nuvisan (Germany), Capsugel (Switzerland), and among others. The key players of this market are mostly focusing on collaborations, partnership, expansion and outsourcing for the clinical trial services.
To know about the assumptions considered for the study download the pdf brochure
Thermo Fisher Scientific Inc. (US)
In 2022, Thermo Fisher Scientific Inc. is focuses on inorganic growth strategies to maintain its market position. The company has strong geographic presence in more than 180 countries across North America, Europe, Asia, the Middle East, Africa, and Latin America. Its is more focusing on providing the clinical trial services through it subsidiary Patheon Pharma. The company is actively engaged in providing complete clinical trial services through different collaborations and partnerships with biopharmaceutical and biotechnology companies.In December 2021, Thermo Fisher Scientific Inc. acquired PPD, Inc. for about USD 16 billion, through which the company provide customers with clinical research services. PPD is now part of Thermo Fisher Scientific’s Laboratory Products and Biopharma Services segment.
Catelent, Inc (US)
Catelent Inc (US) is the leading position in the market in 2022. The company is mainly focus on collaborations, expansion , partnership and service launches. In April 2021, the company has entered into collaborations and partnerships with Stirling Ultracold to enhance its cold chain capabilities. Teva-Takeda Pharmaceutical (Japan), Humanigen (US), and Stirling Ultracold (US), are some of the major partners of the company. The company operates in more than 20+ countries across North America, Europe, Asia Pacific, and Latin America. It has a strong presence in China, Japan, Italy, the UK, France, Belgium, Germany, Argentina, Brazil, Uruguay, Singapore, the US, and Canada.
Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics), Phases, Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, CVD, Infectious, Immunology), End User (Pharma, Biotech, CROs), & Region - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE